top of page

Why sponsor Timepie Longevity Forum?

  • Broad Influence:

As one of the foremost and influential scientific longevity events in China, sponsorship offers exceptional visibility and prestige.

  • Stellar Lineup:

The event boasts the active participation of native and global scientists and CEOs, providing a unique opportunity for networking and collaboration.

  • Well-attended:

With a diverse audience of more than 1000 anti-aging enthusiasts and Key Opinion Leaders (KOLs), your sponsorship can reach a wide and engaged demographic.

  • Rich experience:

Our proven track record of successfully organizing the "TimePie Longevity Forum" for 4 consecutive years, from 2020 to 2023, demonstrates our commitment to excellence and reliability in event management.

2024 Sponsors

organizer

Co-organizer

SuperiorMed & Perennial Hospitals is an international chain of medical institutions established through a strategic partnership between a renowned Chinese national enterprise, the healthcare division of a leading Singaporean industrial conglomerate, and the century-old Black Forest Sanatorium in Germany. In addition to the Chengdu hospital already in operation, new hospitals in Xi'an, Haikou, Beijing, and Hangzhou are scheduled to open between 2024 and 2026. The three major shareholders have strategically expanded their healthcare presence across 16 countries and regions, creating a robust traditional medical network with over 70,000 beds. SuperiorMed & Perennial Hospitals were established in response to the growing demand among high-net-worth patients for tailored and innovative healthcare solutions. The hospitals focus on providing personalized medical services to the global elite patients throughout their lives. Vision: Health, vitality and longevity driven by pioneering innovative healthcare. Mission: To establish a prestigious medical institution recognized worldwide, surpassing the basic public healthcare system through seamless integration of clinical practice, teaching, and scientific research.

sponsors

Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded on June 16, 1992 (stock code: 002603). Guided by the mission of "Inheritance and Innovation, Creating Welfare for Mankind," the company is committed to the goal of "Building a Healthy Future By Science and Technology." Yiling operates with the business philosophy of "Fostering Growth for Employees, Making Contributions to Society, and Creating Value for Shareholders" and consistently adheres to an innovative development strategy that prioritizes technological leadership and market dominance. Yiling pioneered the systematic construction of the Collateral Disease Theory, establishing a unique "Theory-Clinical Practice-Research-Industry-Education" integrated model. This approach has led to the development of a comprehensive industrial cluster spanning medicine, pharmaceuticals, and health. As a result, the Traditional Chinese Medicine Collateral Disease Treatments has been recognized as a National Intangible Cultural Heritage, and the book "Collateral Disease Theory in Practice" is now part of the curriculum at over 40 universities across China. The company has successively undertaken and completed more than 60 scientific research projects at national, provincial and ministerial levels, including projects of the "973 Program", the "863 Program", the National Natural Science Foundation of China, and the National Key Technology R&D Program of China. Yiling has developed more than 10 patented new drugs, including Tongxinluo Capsule for the treatment of coronary heart disease and cerebral infarction, Shensong Yangxin Capsule for managing arrhythmias of both fast and slow types, Qili Qiangxin Capsule for addressing chronic heart failure by treating both symptoms and root causes, Lianhua Qingwen Capsule for combating cold and influenza, and Bazi Bushen Capsule for tonifying the kidneys, nourishing essence, and anti-aging. It has obtained over 800 patents and won six national awards, including the First and Second Prizes of China's National Progress Award in Science and Technology. This enterprise has established five production and research bases in Hebei, Beijing, and other regions, along with over 30 raw material bases for traditional Chinese medicine across China. Our production facilities have obtained international certifications from the United States, the European Union, Canada, New Zealand, and other countries and regions, ensuring a comprehensive quality control system that adheres to global standards. Our patented drug, Lianhua Qingwen Capsule, is now marketed in over 30 countries worldwide. Yiling has ranked among the Top 10 Traditional Chinese Medicine Companies in China, Top 20 Listed Pharmaceutical Company, the Top 500 Chinese Listed Companies by Market Value and the Top 100 Most Valuable Chinese Brands. It has also been honored by the Central Committee of the Communist Party of China as a National Advanced Primary-Level Party Organization.

GeneIII Biotechnology Co., Ltd., based in Jiangsu Province, was founded by Chairman Ding Wei and is a leading Chinese company with a global perspective, specializing in the full cycle of ergothioneine production—from laboratory research to industrialization and commercialization. The company's core technology is developed by Dr. Wang Yang, who holds a Ph.D. in Pharmacy at Oregon State University and a Ph.D. in Biomedical Postdoctoral Research at UIUC University in the United States. As a prominent supplier of high-purity ergothioneine raw materials, GeneIII operates under a cGMP platform, achieving 99.99% purity and utilizing 20-ton fermentation tanks with a monthly production capacity of 3 tons. GeneIII is a key contributor to the drafting committee for China’s industry group standard for ergothioneine. Within just three years of its establishment, the company's sales have surpassed 100 million RMB, and it has become a partner of the renowned "Quality China" program in the synthetic biology sector. GeneIII has also received over 30 awards, including the China Innovative Ingredient Award and the China's Top Formula Beauty Awards. Currently, GeneIII integrates its independently developed ergothioneine into its range of products, such as ergothioneine eye wash, oral capsules, and skincare products, fully embodying the concept of “Makeup and Food Share the Same Origin.”

Bonerge Lifescience is a science-driven company dedicated to the research, development, and production of active ingredients for anti-aging and metabolic health. We closely follow up on the forefront of both domestic and international scientific research, consistently studying and exploring the 12 hallmarks of aging and their underlying metabolic processes. Bonerge is committed to discovering and developing high-quality, potent metabolic nutrients, investigating their pharmacological effects, and advancing innovative health solutions that make healthy aging a realistic choice, unlocking the limitless potential of life. We supply premium ingredients and solutions to the nutraceutical, food, and cosmetics industries, with a focus on anti-aging and metabolic health, such as BeFisetin (Fisetin), Urolithin A, GlucoSober (Dihydroberberine), Golden Oyster Mushroom Extract, Dihydroquercetin, Trigonelline, Salidroside, Polydatin, etc. Our vision is to become the leading brand of high-quality ingredients in China, setting industry standards, fostering positive industry growth, and contributing to a healthier society.

Shanghai Rejuvelab Medical and Health Technology Co., Ltd., known as Rlab, is a longevity technology company specializing in the research and development of cutting-edge anti-aging devices worldwide. Committed to advancing human health through technology, Rlab offers smart anti-aging devices and solutions globally. It employs a multidimensional approach, integrating advanced technologies with anti-aging devices. The company has successfully launched five cutting-edge devices: hyperbaric oxygen chambers, intermittent hypoxic-hyperoxic treatment devices, red light therapy devices, cryotherapy chambers, and floatation tanks. These devices offer innovative recovery tools and techniques, enhancing functionality and performance. They support optimal recovery and treatment while effectively preventing injuries.

Shanghai EGT Synbio Group Co., Ltd. is committed to anti-aging, relying on synthetic biology and cutting-edge plant extraction technology, excellence, for the food, health care products, cosmetics and pharmaceutical industries to provide natural anti-aging active ingredients. The company has established its own cutting-edge technology research and development team, and has established a scientific advisory committee relying on Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences and Shanghai University of Applied Technology. After thousands of experiments, the company has made continuous breakthroughs in the four aspects of strain screening, combined fermentation, enzyme directed evolution, and crystallization purification. Our ergothionein purity is as high as 99.9%, and the rotation ≧+124°, which is the highest purity of ergothionein in the world.

TIMESHOP is an anti-aging nutraceutical brand from Hong Kong. A top scientific research team led by Nobel Prize-winning scientist, Jeffrey C. Hall, gathered in Hong Kong and set up an innovation & research centre. Keeping up with international scientific research results, exploring effective anti-aging conventions around the world, exploring the world's best raw material sources, and maintaining the standards of manufacturing - dedicated in helping more people improve their quality of life. TimeShop attaches great importance to product quality and user experience. All of our products are made from high-quality raw materials from around the world and are produced in factories that far exceed international standards. We promise to strictly adhere to international testing standards and develop high-quality products. At present, the brand has formed a market network with Hong Kong as its manufacturing and R&D center, radiating internationally.

L-Nutra, based in Los Angeles, California, is a pioneering company founded by Dr. Valter Longo, a leading expert in the field of longevity and fasting. Dedicated to enhancing human health and lifespan through innovative nutrition, L-Nutra's approach is grounded in the Fasting Mimicking Diet (FMD) theory. Our flagship product, ProLon, is a scientifically designed meal program that mimics the effects of fasting while providing essential nutrients. ProLon supports weight management, metabolic health, and overall wellness, making it a revolutionary approach to nutrition and healthy aging. By blending cutting-edge science with practical dietary solutions, L-Nutra is committed to transforming lives and promoting a healthier future.

Founded in 2017 by Stanislav Skakun—a pioneer in the quantified self-movement—Biodata is at the forefront of integrating medical, biotechnology, and IT solutions. The company aims to empower both medical professionals and patients by providing a comprehensive ecosystem for processing and storing a wide range of health data, including genetic information, wearable health metrics, medical records, and nutrition data. At the heart of Biodata's offerings is a state-of-the-art digital assistant application that facilitates seamless data processing and management. Additionally, Biodata has developed a unique game design engine that transforms health management into engaging lifestyle quests, promoting proactive health and wellness practices. At Biodata, we are dedicated to revolutionizing health data management, making it easier for individuals and healthcare providers to navigate the complex landscape of modern medicine, thus paving the way for a healthier future.

Beijing Danji Health Technology Co., Ltd. is committed to providing innovative and comprehensive health solutions to create a solid health barrier for the public. Adhering to the four core principles of “Precise Detection, Root Cause Assessment, Personalized Intervention, and Dynamic Management”, we delve deep into the forefront of health technology to tailor personalized services for every client and have developed the “Pretty Care Nutrients” solution, offering you an unprecedented health experience. Compared with traditional nutritional combination products, “Pretty Care Nutrients” place greater emphasis on individual differences and actual needs. With precision analysis carried out on more than 150 detection indicators from users with different health factors, we become able to make root cause assessment from symptom to cause, generating a personalized intervention regimen with targeted nutrients. Before taking these supplements, users need to undergo professional consultations and comprehensive physical examinations, including not only routine biochemical tests, imaging tests and genomic testing, but also functional medical tests such as metabolic system, immune system and endocrine system. Based on the examination data, we will conduct an in-depth analysis of potential health risks of users, and precisely extract the required dosage from our nutritional element library, thereby tailoring your exclusive “Precision Nutrition Solution”.

We are a high-tech enterprise founded by the national talent team of Shenzhen Advanced Technology Research Institute of the Chinese Academy of Sciences. We have an original bioluminescent protein probe technology, pioneered the world's leading bioluminescent detection methods, broke through the bottleneck of existing detection technology, and made large-scale, fast, portable blood assay possible. In the future, it can be widely used in medical care, food industry, agriculture, environmental protection and other fields. We first launched rapid detection instrument and reagents for aging biomarker NAD+, empowering personalized aging interventions. We conduct research on NAD+ regulation and aging medicine with our NAD+ cell lines, which can dynamically and in real-time depict the distribution and metabolic characteristics of NAD+ in subcellular structures, and assist partners in developing new anti-aging products and solutions.

Zhejiang Jing Doctor Beauty Technology Co., Ltd., referred to as "DR.JINGBS", is a senior anti-aging brand for 21 years. DR.JINGBS has grown from a store to a group enterprise, with industries spanning life beauty, medical beauty, body management, hair-raising and black hair, beauty products company and AI technology company, and has a beauty basic education and training school and an American business education platform. As an expert on anti-aging and rejuvenation, DR.JINGBS is committed to making life more beautiful and younger around the three major directions of "anti-aging" business, health care and beauty, functional anti-aging and functional medicine.

The Shanghai South Riverside Stem Cell Innovation Research Public Service Platform is a professional biomedical translational public service platform integrating research, clinical applications, and education. It was jointly established by the state-owned Shanghai Zizhu Emerging Industry Technology Research Institute, located in Minhang District, Shanghai, together with multiple specialized cell research teams. The platform engages in stem cell and immune cell research, with a dedicated cell storage bank, under the technical approval of the Minhang District Science and Technology Commission of Shanghai. The technical team originates from the Stem Cell Therapy Center of the Naval University-affiliated Specialty Hospital (formerly the 455 Hospital). As early as 2010, the center obtained third-class medical technology approval from the General Logistics Department of the Ministry of Health and has accumulated over a decade of experience in stem cell laboratory research and clinical trials. It is the only medical institution in China approved to use autologous peripheral blood stem cell therapy for diabetes and mesenchymal stem cell therapy for Parkinson’s disease, cerebellar atrophy, and liver cirrhosis. Additionally, it is a nationally recognized biological cell transplantation center accredited through the third-class medical technology review of stem cell technologies by the General Logistics Department of the Ministry of Health.

The predecessor of the Hong Kong Longevity Sciences Laboratory was established in 2003 and was incubated from the Chinese University of Hong Kong and the Hong Kong Science and Technology Parks. In 2023, it was reorganized into the current Institute focusing on the field of anti-aging. Cooperating with a number of biotechnology companies to develop the AiCHEMIST-Ai chemical engineering system, which can conduct comprehensive analysis of anti-aging mechanisms and cutting-edge material components and research reports, and cooperate with production and R&D traceability to more effectively develop product formulas and provide technology Staff support.

2024 Media Sponsors

2024 In-Kind Sponsors

NOVOS_logo.png

2024 Special Sponsors

Booth Layout

Layout_edited.jpg

2023 Sponsors